Benefits of conjugated linoleic acid on aging
共轭亚油酸抗衰老的好处
基本信息
- 批准号:7268020
- 负责人:
- 金额:$ 17.44万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2006
- 资助国家:美国
- 起止时间:2006-08-01 至 2009-07-31
- 项目状态:已结题
- 来源:
- 关键词:AcuteAgeAgingAnimal ModelBody WeightBone DensityBone Marrow CellsC57BL/6 MouseCardiovascular DiseasesCardiovascular systemCessation of lifeConjugated Linoleic AcidsCorn OilDataDiabetes MellitusDiaphysesDietDiseaseDistalElderlyFatty acid glycerol estersFemaleFoodFractureGlucoseHypertrophyIncidenceInflammatoryInsulinInsulin ResistanceIntakeInterleukin-6LegLeptinLimb structureLinkLinoleic AcidsMalignant NeoplasmsMeasuresMetaphysicsMetaphysisMorbidity - disease rateMusMuscle WeaknessNon-Insulin-Dependent Diabetes MellitusObesityOlder PopulationOsteoclastsOsteoporosisPainPhysical activityPlasmaPopulationPreventionQuality of lifeSkeletal MuscleSkeletal systemSupplementationTestingTumor Necrosis Factor-alphaWeight Gainage relatedbasebonebone losscytokinedietary supplementsdisabilityfallsfeedingfrailtyfunctional declinehuman TNF proteinhuman studyinterestmalemiddle agemortalitypreventsarcopeniatranscription factor
项目摘要
DESCRIPTION (provided by applicant): Recent rise in obesity due to increased calorie intake and decreased physical activity is linked to the higher incidence of age-related diseases e.g. cardiovascular, type 2 diabetes and certain malignancies which are known to contribute to functional decline and impaired quality of life in older population. With age, obesity increases fat mass and decreases lean body mass which is found to cause bone loss and subsequent fractures in the elderly. In fact, muscle weakness is the major contributing factor in causing frailty; resulting in disability, acute illness, pain and early deaths. In recent years, there has been a growing interest in conjugated linoleic acid (CLA) as a possible dietary supplement to reduce obesity. CLA is found to decrease fat mass and increase lean body mass in several animal models. Similar results have also been obtained in some human studies. We hypothesize that supplementing low dietary CLA particularly during midlife or late age will prevent sarcopenia and osteoporosis, thereby decreasing falls and fractures, and preventing both morbidity and mortality in the elderly. To establish this clinically related hypothesis we propose to undertake the following studies. Specific aim 1. To measure age-related changes in fat and lean body mass in 6-12, 12-18 and 18-24 months old C57BL/6 mice (mildly prone to develop type 2 diabetes and osteoporosis), with or without CLA (0.5%), and correlate with plasma glucose, insulin, leptin levels and changes in TNF-alpha and IL-6 cytokine levels. Specific Aim 2. To measure age-related changes in BMD, activation of osteoclasts and osteoclast specific transcription factors in bone marrow cells of mice, with and without CLA supplementation. Based on our preliminary data in young mice, if our proposed studies in older mice find beneficial effect of CLA against age related sarcopenia and BMD loss, the results would be very useful to test the feasibility of using CLA as a dietary supplement in the baby boomer population.
描述(申请人提供):最近由于卡路里摄入量增加和体力活动减少而导致的肥胖率上升与年龄相关疾病的更高发病率有关,例如心血管疾病、2型糖尿病和某些恶性肿瘤,这些疾病被认为是导致老年人功能下降和生活质量下降的原因。随着年龄的增长,肥胖会增加脂肪质量,减少瘦体重,这会导致老年人的骨质流失和随后的骨折。事实上,肌肉无力是导致虚弱的主要因素;导致残疾、急性疾病、疼痛和过早死亡。近年来,共轭亚油酸(CLA)作为一种可能的减肥膳食补充剂受到了越来越多的关注。在几种动物模型中,共轭亚油酸被发现可以减少脂肪质量和增加瘦体重。在一些人体研究中也得到了类似的结果。我们推测,特别是在中年或晚年补充低饮食的CLA可以预防骨质疏松症和骨质疏松症,从而减少跌倒和骨折,并防止老年人的发病率和死亡率。为了建立这一临床相关假说,我们建议进行以下研究。具体目的1.测定6-12、12-18和18-24个月龄C57BL/6小鼠(轻度易患2型糖尿病和骨质疏松症)在添加或不添加CLA(0.5%)的情况下脂肪和瘦体质量的增龄性变化,并与血糖、胰岛素、瘦素水平以及肿瘤坏死因子-α和IL-6细胞因子水平的变化进行相关性研究。具体目的2.测定补充和不补充共轭亚油酸对小鼠骨髓细胞中破骨细胞和破骨细胞特异性转录因子的激活和骨密度的影响。基于我们在年轻小鼠中的初步数据,如果我们在老年小鼠中进行的拟议研究发现共轭亚油酸对年龄相关的骨骼减少和骨密度丢失有好处,结果将非常有助于测试在婴儿潮一代人群中使用共轭亚油酸作为饮食补充剂的可行性。
项目成果
期刊论文数量(5)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Combination of conjugated linoleic acid with fish oil prevents age-associated bone marrow adiposity in C57Bl/6J mice.
- DOI:10.1016/j.jnutbio.2010.03.015
- 发表时间:2011-05
- 期刊:
- 影响因子:5.6
- 作者:Halade, Ganesh V.;Rahman, Md M.;Williams, Paul J.;Fernandes, Gabriel
- 通讯作者:Fernandes, Gabriel
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
GABRIEL J J FERNANDES其他文献
GABRIEL J J FERNANDES的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('GABRIEL J J FERNANDES', 18)}}的其他基金
Therapeutic Value of Fish Oil Rx on SLE and Bone Loss in Mice
鱼油 Rx 对小鼠 SLE 和骨丢失的治疗价值
- 批准号:
8214697 - 财政年份:2008
- 资助金额:
$ 17.44万 - 项目类别:
Therapeutic Value of Fish Oil Rx on SLE and Bone Loss in Mice
鱼油 Rx 对小鼠 SLE 和骨丢失的治疗价值
- 批准号:
7537225 - 财政年份:2008
- 资助金额:
$ 17.44万 - 项目类别:
Therapeutic Value of Fish Oil Rx on SLE and Bone Loss in Mice
鱼油 Rx 对小鼠 SLE 和骨丢失的治疗价值
- 批准号:
7303063 - 财政年份:2008
- 资助金额:
$ 17.44万 - 项目类别:
Therapeutic Value of Fish Oil Rx on SLE and Bone Loss in Mice
鱼油 Rx 对小鼠 SLE 和骨丢失的治疗价值
- 批准号:
7783829 - 财政年份:2008
- 资助金额:
$ 17.44万 - 项目类别:
Prolongation of lifespan by n-3 fatty acids and calorie restriction
通过 n-3 脂肪酸和热量限制延长寿命
- 批准号:
7372969 - 财政年份:2008
- 资助金额:
$ 17.44万 - 项目类别:
Therapeutic Value of Fish Oil Rx on SLE and Bone Loss in Mice
鱼油 Rx 对小鼠 SLE 和骨丢失的治疗价值
- 批准号:
8007407 - 财政年份:2008
- 资助金额:
$ 17.44万 - 项目类别:
Prolongation of lifespan by n-3 fatty acids and calorie restriction
通过 n-3 脂肪酸和热量限制延长寿命
- 批准号:
7795853 - 财政年份:2008
- 资助金额:
$ 17.44万 - 项目类别:
Prolongation of lifespan by n-3 fatty acids and calorie restriction
通过 n-3 脂肪酸和热量限制延长寿命
- 批准号:
7576806 - 财政年份:2008
- 资助金额:
$ 17.44万 - 项目类别:
EFFECTS OF n-3 FATTY ACIDS AND EXERCISE ON OSTEOPOROSIS
n-3 脂肪酸和运动对骨质疏松症的影响
- 批准号:
7004505 - 财政年份:2005
- 资助金额:
$ 17.44万 - 项目类别:
相似国自然基金
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
- 批准号:JCZRQN202500010
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
- 批准号:2025JJ70209
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
- 批准号:
- 批准年份:2024
- 资助金额:0 万元
- 项目类别:面上项目
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
- 批准号:2023JJ50274
- 批准年份:2023
- 资助金额:0.0 万元
- 项目类别:省市级项目
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
- 批准号:
- 批准年份:2022
- 资助金额:33 万元
- 项目类别:地区科学基金项目
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
- 批准号:n/a
- 批准年份:2022
- 资助金额:10.0 万元
- 项目类别:省市级项目
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
- 批准号:81973577
- 批准年份:2019
- 资助金额:55.0 万元
- 项目类别:面上项目
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
- 批准号:81602908
- 批准年份:2016
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
高血糖激活滑膜AGE-RAGE-PKC轴致骨关节炎易感的机制研究
- 批准号:81501928
- 批准年份:2015
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
相似海外基金
The Phenomenon of Stem Cell Aging according to Methylation Estimates of Age After Hematopoietic Stem Cell Transplantation
根据造血干细胞移植后甲基化年龄估算干细胞衰老现象
- 批准号:
23K07844 - 财政年份:2023
- 资助金额:
$ 17.44万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Analysis of Age-dependent Functional Changes in Skeletal Muscle CB1 Receptors by an in Vitro Model of Aging-related Muscle Atrophy
通过衰老相关性肌肉萎缩的体外模型分析骨骼肌 CB1 受体的年龄依赖性功能变化
- 批准号:
22KJ2960 - 财政年份:2023
- 资助金额:
$ 17.44万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Joint U.S.-Japan Measures for Aging and Dementia Derived from the Prevention of Age-Related and Noise-induced Hearing Loss
美日针对预防与年龄相关和噪声引起的听力损失而导致的老龄化和痴呆症联合措施
- 批准号:
23KK0156 - 财政年份:2023
- 资助金额:
$ 17.44万 - 项目类别:
Fund for the Promotion of Joint International Research (International Collaborative Research)
The Effects of Muscle Fatigability on Gait Instability in Aging and Age-Related Falls Risk
肌肉疲劳对衰老步态不稳定性和年龄相关跌倒风险的影响
- 批准号:
10677409 - 财政年份:2023
- 资助金额:
$ 17.44万 - 项目类别:
Characterizing gut physiology by age, frailty, and sex: assessing the role of the aging gut in "inflamm-aging"
按年龄、虚弱和性别表征肠道生理学特征:评估衰老肠道在“炎症衰老”中的作用
- 批准号:
497927 - 财政年份:2023
- 资助金额:
$ 17.44万 - 项目类别:
Deciphering the role of osteopontin in the aging eye and age-related macular degeneration
破译骨桥蛋白在眼睛老化和年龄相关性黄斑变性中的作用
- 批准号:
10679287 - 财政年份:2023
- 资助金额:
$ 17.44万 - 项目类别:
Role of AGE/RAGEsignaling as a driver of pathological aging in the brain
AGE/RAGE信号传导作为大脑病理性衰老驱动因素的作用
- 批准号:
10836835 - 财政年份:2023
- 资助金额:
$ 17.44万 - 项目类别:
Elucidation of the protein kinase NLK-mediated aging mechanisms and treatment of age-related diseases
阐明蛋白激酶NLK介导的衰老机制及年龄相关疾病的治疗
- 批准号:
23K06378 - 财政年份:2023
- 资助金额:
$ 17.44万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Underlying mechanisms of age-related changes in ingestive behaviors: From the perspective of the aging brain and deterioration of the gustatory system.
与年龄相关的摄入行为变化的潜在机制:从大脑老化和味觉系统退化的角度来看。
- 批准号:
23K10845 - 财政年份:2023
- 资助金额:
$ 17.44万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Targeting Age-Activated Proinflammatory Chemokine Signaling by CCL2/11 to Enhance Skeletal Muscle Regeneration in Aging
通过 CCL2/11 靶向年龄激活的促炎趋化因子信号传导以增强衰老过程中的骨骼肌再生
- 批准号:
478877 - 财政年份:2023
- 资助金额:
$ 17.44万 - 项目类别:
Operating Grants